Latest News

NUS Scientists Discover the 'Switch' That Makes Breast Cancer Cells Aggressive

Congratulations to Dr Alan Prem Kumar from the Cancer Science Institute of Singapore (CSI Singapore) at NUS and NUS Yong Loo Lin School of Medicine, together with Professor Shazib Pervaiz and Associate Professor Marie-Veronique Clement from NUS Yong Loo Lin School of Medicine for the discovery.

Read More

NUS Medicine Researchers Develop Potential Oral Anti-Diabetic Drug

Congratulations to Associate Professor Sim Meng Kwoon, retired faculty member of the Department of Pharmacology, at NUS Medicine, for developing an oral anti-diabetic drug and have successfully completed Phase I clinical trial. The drug improves the action of insulin and reduces damaging chronic inflammation that accompanies diabetes.

Read More

NUS-Led Study: Consumption of A Bioactive Compound From Neem Plant Could Significantly Suppress Development Of Prostate Cancer

Congratulation to Associate Professor Gautam Sethi from the Department of Pharmacology at the Yong Loo Lin School of Medicine, who led a team of international researchers, at the National University of Singapore (NUS), has found that nimbolide, a bioactive terpenoid compound derived from Azadirachta indica or more commonly known as the neem plant, could reduce the size of prostate tumour by up to 70 per cent and suppress its spread or metastasis by half.

Read More

More News   Events Calendar